At the same time, Stedical Scientific launched a multi-center clinical trial to evaluate the safety and efficacy of PermeaDerm ® in China. The first patient with deep second-degree burns was enrolled, ...
CARLSBAD, CA / ACCESSWIRE / December 29, 2015 / University of Rochester (Dr. Phipps), PermeaDerm, Inc. (Dr. Woodroof) and BioDot Inc. (Dr. Lemmo) are collaborating to make a Temporary Skin Substitute ...
Avita Medical Ltd ((RCEL)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Avita Medical Ltd is conducting a clinical study titled ‘A Prospective Post-Market Multicenter Randomized Controlled Clinical Study to Investigate Clinical Outcomes and Associated Costs When ...
AVITA Medical, Inc., a commercial-stage regenerative medicine company, announced it has entered into an exclusive multi-year distribution agreement with Stedical Scientific, Inc. to commercialize ...
Avita Medical (RCEL) announced it has entered into a new contract manufacturing agreement for PermeaDerm Biosynthetic Wound Matrix, along with an amendment to its existing exclusive distribution ...
AVITA Medical (NASDAQ:RCEL) said on Monday it has signed a new contract manufacturing agreement for PermeaDerm biosynthetic wound matrix with Stedical Scientific. Under the new contract manufacturing ...
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific
VALENCIA, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: Avita Medical Ltd is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback